AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Releases Hard-shell Capsules to Clinical Evaluation, page-12

  1. 6,830 Posts.
    lightbulb Created with Sketch. 604
    "“We remain focused on making AusCann’s capsules available for prescription to patients
    in Australia during the first half of 2020"
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.